Accardi Mario Alberto
Officer at CNTA
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Dec 9, 2025
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CNTACentessa Pharmaceuticals plcOfficer
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice CNTANoticeSep 16, 2025 2025
Filed to sell 8,172 shares ($180k)
Accardi Mario Alberto, Officer
10b5-1 plan1x usual sizeFiling
- 2 Form 4 sale CNTARoutineSep 16, 2025 same day
Sold 8,172 shares at $21.39 ($175k)
Accardi Mario Alberto, President, Orexin Program
10b5-1 planSold 4% of holdings ($4.4M position)197,394 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice CNTANoticeOct 27, 2025 +41 days
Filed to sell 8,000 shares ($200k)
Accardi Mario Alberto, Officer
10b5-1 plan1x usual sizeFiling
- 4 Form 4 sale CNTARoutineOct 27, 2025 same day
Sold 8,000 shares at $25.00 ($200k)
Accardi Mario Alberto, President, Orexin Program
10b5-1 planSold 4% of holdings ($5.1M position)194,394 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 4 sale CNTARoutineDec 8, 2025 +42 days
Sold 10,000 shares at $30.00 ($300k)
Accardi Mario Alberto, President, Orexin Program
10b5-1 planSold 5% of holdings ($6M position)188,801 shares left1.2x usual sizeFollows a Form 144Filing
- 6 Form 144 notice CNTANoticeDec 8, 2025 same day
Filed to sell 10,000 shares ($300k)
Accardi Mario Alberto, Officer
10b5-1 plan1.2x usual sizeFiling
- 7 Form 4 sale CNTARoutineDec 9, 2025 +1 day
Sold 10,000 shares at $28.83 ($288k)
Accardi Mario Alberto, President, Orexin Program
10b5-1 planSold 5.3% of holdings ($5.4M position)178,801 shares left1.2x usual sizeFollows a Form 144Filing
- 8 Form 144 notice CNTANoticeDec 9, 2025 same day
Filed to sell 10,000 shares ($293k)
Accardi Mario Alberto, Officer
10b5-1 plan1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Dec 9, 2025 | CNTA | Officer | Form 144 notice | 10,000 | $293k | Notice | SEC | |
| Dec 9, 2025 | Dec 9, 2025 | CNTA | President, Orexin Program | Form 4 sale | 10,000 | $288k | 5.3% | Routine | SEC |
| Dec 8, 2025 | Dec 8, 2025 | CNTA | Officer | Form 144 notice | 10,000 | $300k | Notice | SEC | |
| Dec 8, 2025 | Dec 8, 2025 | CNTA | President, Orexin Program | Form 4 sale | 10,000 | $300k | 5.0% | Routine | SEC |
| Oct 27, 2025 | Oct 27, 2025 | CNTA | President, Orexin Program | Form 4 sale | 8,000 | $200k | 4.0% | Routine | SEC |
| Oct 27, 2025 | Oct 27, 2025 | CNTA | Officer | Form 144 notice | 8,000 | $200k | Notice | SEC | |
| Sep 16, 2025 | Sep 16, 2025 | CNTA | President, Orexin Program | Form 4 sale | 8,172 | $175k | 4.0% | Routine | SEC |
| Sep 16, 2025 | Sep 16, 2025 | CNTA | Officer | Form 144 notice | 8,172 | $180k | Notice | SEC | |
| Sep 9, 2025 | Sep 11, 2025 | CNTA | President, Orexin Program | Form 4 sale | 7,000 | $140k | 3.3% | Routine | SEC |
| Sep 9, 2025 | Sep 9, 2025 | CNTA | Officer | Form 144 notice | 7,000 | $140k | Notice | SEC | |
| Jul 29, 2025 | Jul 30, 2025 | CNTA | President, Orexin Program | Form 4 sale | 8,322 | $127k | 3.8% | Routine | SEC |
| Jul 29, 2025 | Jul 29, 2025 | CNTA | Officer | Form 144 notice | 8,322 | $128k | Notice | SEC | |
| Jun 25, 2025 | Jun 25, 2025 | CNTA | Officer | Form 144 notice | 15,000 | $210k | Notice | SEC | |
| Jun 24, 2025 | Jun 25, 2025 | CNTA | President, Orexin Program | Form 4 sale | 15,000 | $210k | 6.5% | Routine | SEC |